| Call | Ticker | Start Date | Time | Start Price | Today's Change | Stock Gain | versus S&P | Take |
 | YHOO | 05/06/08 | 1 Quarter | $25.54 | 0.00 (0.00%) | -16.41% | -3.95% | View Take |
Oh yes, I hit big the other day on my put option for this company. Now that Microsoft has moved out of the way lets bring in some more bids to bump this stock up. :-) Don't forget that yahoo is still a very nice looking takeover target. ( Close) |
| MA | 05/06/08 | 1 Quarter | $290.94 | 0.00 (0.00%) | -12.73% | 9.53% | View Take |
ahhh credit cards... I hate there interest rates but, I love there stocks. Oh, what a perfect business structure they have... ( Close) |
| NGA | 05/02/08 | 1 Year | $5.59 | 0.00 (0.00%) | 42.40% | 70.04% | View Take |
I'm long on NGA due to its strong fundementals and Low PEG ( Close) |
| FUQI | 04/11/08 | 1 Year | $6.40 | 0.00 (0.00%) | 33.44% | 61.90% | View Take |
This is an undervalued stock with a high profit margin. I am very attracted to it and rate it a Strong Buy with a 1yr price target of $8.44 ( Close) |
| VPHM | 02/22/08 | 2 Years | $9.43 | 0.00 (0.00%) | 18.66% | 25.14% | View Take |
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases. The Company focuses on commercialization and development programs on products used by physician specialists or in hospital settings. ViroPharma has one marketed product and multiple product candidates in clinical development. It markets and sells Vancocin capsules hydrochloride (HCl), the oral capsule formulation of vancomycin hydrochloride, in the United States and its territories. They are a company that consists of 67 Employees. There stock is trading around 8 times earnings with an excellent set of financial statements. ( Close) |
| VPHM | 02/22/08 | 2 Years | $9.43 | 0.00 (0.00%) | 18.66% | 25.14% | View Take |
ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases. The Company focuses on commercialization and development programs on products used by physician specialists or in hospital settings. ViroPharma has one marketed product and multiple product candidates in clinical development. It markets and sells Vancocin capsules hydrochloride (HCl), the oral capsule formulation of vancomycin hydrochloride, in the United States and its territories. They are a company that consists of 67 Employees. There stock is trading around 8 times earnings with an excellent set of financial statements. ( Close) |